Serveur d'exploration sur le cobalt au Maghreb - Analysis (Tunisie)

Index « Auteurs » - entrée « M. Maalej »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
M. M. Chabouni < M. Maalej < M. Magoni  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000158 (2004) L. Kochbati [Tunisie] ; N Kédidi Ben Romdhane ; K. Mrad ; C. Nasr ; D E Ben Salah ; K. Ben Romdhane ; M. Maalej[Solitary bone plasmocytoma: treatment and outcome features].
000167 (2003) L. Kochbati [Tunisie] ; H. Boussen ; F. Benna ; Z. Belhaj Ali ; A. Gammoudi ; N. Bouaouina ; M. Besbes ; L. Ghilen ; K. Rahal ; M. Maalej[Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz].

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Adult
2Female
2Humans
2Male
2Middle Aged
2Retrospective Studies
1Adolescent
1Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
1Antineoplastic Combined Chemotherapy Protocols (adverse effects)
1Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
1Biopsy
1Bleomycin (administration & dosage)
1Bone Neoplasms (drug therapy)
1Bone Neoplasms (pathology)
1Bone Neoplasms (radiotherapy)
1Bone Neoplasms (surgery)
1Child
1Cobalt Radioisotopes (therapeutic use)
1Combined Modality Therapy
1Dacarbazine (administration & dosage)
1Doxorubicin (administration & dosage)
1Follow-Up Studies
1Hodgkin Disease (drug therapy)
1Hodgkin Disease (radiotherapy)
1Incidence
1Laminectomy
1Mechlorethamine (adverse effects)
1Multiple Myeloma (etiology)
1Neoplasms, Second Primary (epidemiology)
1Neoplasms, Second Primary (etiology)
1Plasmacytoma (drug therapy)
1Plasmacytoma (pathology)
1Plasmacytoma (radiotherapy)
1Plasmacytoma (surgery)
1Prednisone (adverse effects)
1Procarbazine (adverse effects)
1Radioisotope Teletherapy
1Radiotherapy, High-Energy
1Risk Factors
1Spinal Neoplasms (drug therapy)
1Spinal Neoplasms (pathology)
1Spinal Neoplasms (radiotherapy)
1Spinal Neoplasms (surgery)
1Tibia (pathology)
1Time Factors
1Treatment Outcome
1Tunisia (epidemiology)
1Vinblastine (administration & dosage)
1Vincristine (adverse effects)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/CobaltMaghrebV1/Data/Tunisie/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Tunisie/Analysis/Author.i -k "M. Maalej" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Tunisie/Analysis/Author.i  \
                -Sk "M. Maalej" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Tunisie/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Terre
   |area=    CobaltMaghrebV1
   |flux=    Tunisie
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    M. Maalej
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Tue Nov 14 12:56:51 2017. Site generation: Mon Feb 12 07:59:49 2024